-
The effects of optogenetically activated orexin/hypocretin neurons on the mesolimbic reward pathway
https://braincanada.ca/funded-grants/the-effects-of-optogenetically-activated-orexin-hypocretin-neurons-on-the-mesolimbic-reward-pathwayMr. Baimel’s work focuses upon the role of the neuropeptide, orexin, and its role in modulating the neural region which regulates reward sensations, the ventral tegmental area (VTA). Project Overview Mr. Baimel’s work focuses upon the role of the neuropeptide, orexin, and its role in modulating the...
-
The endocannabinoid system: a master regulator of brain and gut health in mood disorders
https://braincanada.ca/funded-grants/the-endocannabinoid-system-a-master-regulator-of-brain-and-gut-health-in-mood-disordersDepression will affect 1 out of 5 individuals in their lifetime. Project Overview Depression will affect 1 out of 5 individuals in their lifetime. Antidepressant treatments are not effective for 30-50% patients, only 30% completely remit and do not suffer from another depressive episode, suggesting...
-
The Experience of Pain for Black Women with Postpartum Depression
https://braincanada.ca/funded-grants/the-experience-of-pain-for-black-women-with-postpartum-depressionMy project aims to understand how racial identity is influencing the way Black women experience post-partum depression (PPD). Project Overview My project aims to understand how racial identity is influencing the way Black women experience post-partum depression (PPD). Persistent stress from social...
-
The Experimental Imaging Centre: a Local Brain Canada Platform for Preclinical MR Neuroimaging
https://braincanada.ca/funded-grants/the-experimental-imaging-centre-a-local-brain-canada-platform-for-preclinical-mr-neuroimagingThe Experimental Imaging Centre Brain Canada Platform provides state of the art pre-clinical imaging to the neuroscience research community. Project Overview The Experimental Imaging Centre Brain Canada Platform provides state of the art pre-clinical imaging to the neuroscience research community....
-
The feasibility of hyperpolarized 13C-Pyruvate MRI for monitoring patients with intracranial metastasis
https://braincanada.ca/funded-grants/the-feasibility-of-hyperpolarized-13c-pyruvate-mri-for-monitoring-patients-with-intracranial-metastasisSurgery and radiation are standard treatments for cancer that has spread to the brain. Project Overview Surgery and radiation are standard treatments for cancer that has spread to the brain. Recent research has revealed that cancer cells with high levels of the chemical lactate are aggressive and...
-
The FIERCE Project: Examining the Effectiveness and Implementation of an Anxiety Intervention for Youth with ADHD
https://braincanada.ca/funded-grants/the-fierce-project-examining-the-effectiveness-and-implementation-of-an-anxiety-intervention-for-youth-with-adhdAlmost 9% of Canadians have ADHD, however it is likely higher as more girls and women are being diagnosed. Project Overview Almost 9% of Canadians have ADHD, however it is likely higher as more girls and women are being diagnosed. Up to 50% of youth with ADHD also have an anxiety disorder, which...
-
The Frontier Trial – Field Randomization of NA-1 Treatment In Early Responders
https://braincanada.ca/funded-grants/the-frontier-trial-field-randomization-of-na-1-treatment-in-early-respondersStroke is a life threatening emergency caused by blocked arteries that affects 45,000 Canadians a year. Each hour a stroke is left untreated means brain cells are dying. Project Overview Stroke is a life threatening emergency caused by blocked arteries that affects 45,000 Canadians a year. Each...
-
The future of ALS research
https://braincanada.ca/about/news-updates/the-future-of-als-researchThe ALS Society of Canada and Brain Canada select latest Career Transition Award to support innovative ALS research The ALS Society of Canada (ALS Canada) and Brain Canada are investing in the future of innovative scientists who are changing the landscape of amyotrophic lateral sclerosis (ALS)...
-
The Future of Brain Research
https://braincanada.ca/about/news-updates/the-future-of-brain-researchPHOTO: From left : Dr. Marie-Eve Paquet, Brain Canada CEO & President Dr. Viviane Poupon and Dr. Yves De Koninck, in Quebec City May 12, 2025 Brain Canada is proud to announce that Dr. Marie-Eve Paquet and Dr. Yves De Koninck have been awarded a 2024 Platform Support Grant (PSG) in recognition of...
-
The Future of Huntington Research
https://braincanada.ca/about/news-updates/the-future-of-huntington-researchNew Funding for the Future of Huntington Disease Research in Canada Brain Canada joins the Huntington Society of Canada to fund seven undergraduate student fellowships Huntington disease (HD) is a hereditary, neurodegenerative illness with physical, cognitive and mental health symptoms. It is caused...
Skip to main content
